Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.
IPO Year:
Exchange: NYSE
Website: safeguard.com
RADNOR, Pa., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") has announced today that it filed Form 25 with the Securities and Exchange Commission (the "SEC") to voluntarily delist its shares of common stock from trading on The Nasdaq Stock Market LLC ("Nasdaq") in connection with its previously announced plan to deregister its common stock under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and to delist the Company's common stock from trading on Nasdaq (referred to as the "Transaction"). The Company expects that the delisting will occur ten days after the filing of Form 25 so that trading will be suspended
Radnor, Pa, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") has announced today that it notified The Nasdaq Stock Market LLC ("Nasdaq") that it intends to file Form 25 with the Securities and Exchange Commission (the "SEC") on February 2, 2024 to voluntarily delist its shares of common stock from trading on Nasdaq in connection with its previously announced plan to deregister its common stock under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company expects that the delisting will occur ten days after the filing of Form 25, at which point, the Company intends to file a Form 15 with the SEC certifying
RADNOR, Pa., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that, as authorized by its Board of Directors (the "Board"), the Company will file amendments to its articles of incorporation with the Pennsylvania Department of State to effectuate a reverse stock split at a ratio of 1-for-100, to be followed immediately by a forward stock split at a ratio of 100-for-1 (collectively referred to as "stock splits"), which are expected to become effective on or about January 12, 2024, and the Company's common stock is expected to begin trading on The Nasdaq Stock Market LLC ("Nasdaq") on a post-forward stock split basis upon
RADNOR, Pa., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that, after the Company's shareholders adopted amendments to the articles of incorporation at the Special Meeting of Shareholders held on December 15, 2023 (the "Special Meeting") to effect a reverse stock split, to be followed immediately by a forward stock split, at a ratio of (i) not less than 1-for-50 and not greater than 1-for-100, in the case of the reverse stock split, and (ii) not less than 50-for-1 and not greater than 100-for-1, in the case of the forward stock split (collectively referred to as "stock splits"), the Company's Board of Directors (t
RADNOR, Pa., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that on December 7, 2023, its Board of Directors (the "Board") declared a special cash dividend of $0.35 per share, payable on December 28, 2023 to shareholders of record as of the close of business on December 19, 2023 (the "Record Date"). The dividend is contingent on the adoption of amendments to the Company's articles of incorporation effecting the reverse stock split and the forward stock split of the Company's common stock at the Special Meeting of Shareholders to be held on December 15, 2023, and the Board thereafter giving effect to the Company's
RADNOR, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced financial results for the three and nine months ended September 30, 2023. THIRD QUARTER 2023 HIGHLIGHTS Financial Results Cash, cash equivalents and restricted cash totaled $15.7 million at September 30, 2023.The carrying value of the Company's ownership interests totaled $14.8 million at September 30, 2023. The total cost of the Company's ownership interests was $122.8 million.Net income for the three months ended September 30, 2023 was $0.9 million, or $0.06 per basic and fully diluted share, as compared with a net loss of $3.2 million, or $0.19 per bas
Radnor, Pa, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) will release its financial results for the third quarter ended September 30, 2023 after the market close on Thursday, November 2, 2023. CONFERENCE CALL AND WEBCAST DETAILS Please call 10-15 minutes prior to the call to register. Date: Thursday, November 2, 2023 Time: 5:00 pm ET Live Number: 877-407-0989 Webcast link: https://www.webcast-eqs.com/register/safeguard110223/en Speakers: Chief Executive Officer, Eric C. Salzman; and Senior Vice President and Chief Financial Officer, Mark A. Herndon Format: Discussion of the third quarter of 2023 financial results followed by Q&
RADNOR, Pa., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that its Board of Directors (the "Board") has approved a plan to cease the registration of the Company's common stock under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), following the completion of a proposed reverse stock split transaction, which will be followed immediately by a forward stock split, and to delist its shares of common stock from trading on The Nasdaq Stock Market LLC ("Nasdaq"). In order to deregister its shares of common stock, the Company must reduce its number of shareholders of record to below 300. To accom
RADNOR, Pa., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced financial results for the three and six months ended June 30, 2023. SECOND QUARTER 2023 HIGHLIGHTS Financial Results Cash, cash equivalents and restricted cash totaled $15.1 million at June 30, 2023.The carrying value of the Company's ownership interests totaled $13.0 million at June 30, 2023. The total cost of the Company's ownership interests was $138.4 million.Net loss for the three months ended June 30, 2023 was $2.9 million, or $0.18 per share, as compared with a net income of $0.5 million, or $0.03 per share, for the same period in 2022.Net loss for
RADNOR, PA, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) will release its financial results for the second quarter ended June 30, 2023 after the market close on Thursday, August 10, 2023. CONFERENCE CALL AND WEBCAST DETAILSPlease call 10-15 minutes prior to the call to register. Date: Thursday, August 10, 2023 Time: 5:00 pm ET Live Number: 877-407-0989 Webcast link: https://www.webcast-eqs.com/register/safeguardscientific081023/en Speakers: Chief Executive Officer, Eric C. Salzman; and Senior Vice President and Chief Financial Officer, Mark A. Herndon Format: Discussion of the second quarter of 2023 financial results followed by Q&A The replay
15-12G - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)
SC 13E3/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)
EFFECT - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)
8-K - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)
POS AM - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)
S-8 POS - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)
S-8 POS - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)
S-8 POS - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)
S-8 POS - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)
8-K - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)
TheracosBio today announced the appointment of former US Congressman Jim Greenwood to the Board of Directors of its parent company and Jeff McGroarty, MBA, as its Chief Financial Officer. Congressman Greenwood is an established leader in life sciences across business and public policy, and Mr. McGroarty has served as a CFO of public and private life sciences and technology companies. Both newly appointed team members will help shape the commercial strategy for Brenzavvy™ (bexagliflozin), a recently FDA-approved treatment for type 2 diabetes. "Accomplished leaders, Jim and Jeff will be valuable members of our team at this critical time for TheracosBio," said Albert R. Collinson, Ph.D., Pres
RADNOR, Pa., Dec. 21, 2020 /PRNewswire/ -- Safeguard Scientifics, Inc. (NYSE:SFE) announced today that Eric C. Salzman has been appointed Chief Executive Officer, effective December 21, 2020. Since April 1, 2020, Mr. Salzman has served as the Company's Chief Restructuring Officer. As CEO, Mr. Salzman will continue to focus on the value maximization and monetization of Safeguard's interests in its portfolio companies as well as the management of Safeguard's operations. "Since joining Safeguard earlier this year, we have been impressed with Eric's progress towards executing on Safeguard's strategy to drive value creation from the portfolio and return capital to our shareholders," said Robe
SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)
SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)
SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)
SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)
SC 13G - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)
SC 13G - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)
SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)
SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)
SC 13G - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)
SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)
4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)
4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)
4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)
4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)
3 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)
4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)
4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)
4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)
4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)
4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)
RADNOR, Pa., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that, after the Company's shareholders adopted amendments to the articles of incorporation at the Special Meeting of Shareholders held on December 15, 2023 (the "Special Meeting") to effect a reverse stock split, to be followed immediately by a forward stock split, at a ratio of (i) not less than 1-for-50 and not greater than 1-for-100, in the case of the reverse stock split, and (ii) not less than 50-for-1 and not greater than 100-for-1, in the case of the forward stock split (collectively referred to as "stock splits"), the Company's Board of Directors (t
RADNOR, Pa., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that on December 7, 2023, its Board of Directors (the "Board") declared a special cash dividend of $0.35 per share, payable on December 28, 2023 to shareholders of record as of the close of business on December 19, 2023 (the "Record Date"). The dividend is contingent on the adoption of amendments to the Company's articles of incorporation effecting the reverse stock split and the forward stock split of the Company's common stock at the Special Meeting of Shareholders to be held on December 15, 2023, and the Board thereafter giving effect to the Company's
RADNOR, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced financial results for the three and nine months ended September 30, 2023. THIRD QUARTER 2023 HIGHLIGHTS Financial Results Cash, cash equivalents and restricted cash totaled $15.7 million at September 30, 2023.The carrying value of the Company's ownership interests totaled $14.8 million at September 30, 2023. The total cost of the Company's ownership interests was $122.8 million.Net income for the three months ended September 30, 2023 was $0.9 million, or $0.06 per basic and fully diluted share, as compared with a net loss of $3.2 million, or $0.19 per bas
Radnor, Pa, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) will release its financial results for the third quarter ended September 30, 2023 after the market close on Thursday, November 2, 2023. CONFERENCE CALL AND WEBCAST DETAILS Please call 10-15 minutes prior to the call to register. Date: Thursday, November 2, 2023 Time: 5:00 pm ET Live Number: 877-407-0989 Webcast link: https://www.webcast-eqs.com/register/safeguard110223/en Speakers: Chief Executive Officer, Eric C. Salzman; and Senior Vice President and Chief Financial Officer, Mark A. Herndon Format: Discussion of the third quarter of 2023 financial results followed by Q&
RADNOR, Pa., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that its Board of Directors (the "Board") has approved a plan to cease the registration of the Company's common stock under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), following the completion of a proposed reverse stock split transaction, which will be followed immediately by a forward stock split, and to delist its shares of common stock from trading on The Nasdaq Stock Market LLC ("Nasdaq"). In order to deregister its shares of common stock, the Company must reduce its number of shareholders of record to below 300. To accom
RADNOR, Pa., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced financial results for the three and six months ended June 30, 2023. SECOND QUARTER 2023 HIGHLIGHTS Financial Results Cash, cash equivalents and restricted cash totaled $15.1 million at June 30, 2023.The carrying value of the Company's ownership interests totaled $13.0 million at June 30, 2023. The total cost of the Company's ownership interests was $138.4 million.Net loss for the three months ended June 30, 2023 was $2.9 million, or $0.18 per share, as compared with a net income of $0.5 million, or $0.03 per share, for the same period in 2022.Net loss for
RADNOR, PA, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) will release its financial results for the second quarter ended June 30, 2023 after the market close on Thursday, August 10, 2023. CONFERENCE CALL AND WEBCAST DETAILSPlease call 10-15 minutes prior to the call to register. Date: Thursday, August 10, 2023 Time: 5:00 pm ET Live Number: 877-407-0989 Webcast link: https://www.webcast-eqs.com/register/safeguardscientific081023/en Speakers: Chief Executive Officer, Eric C. Salzman; and Senior Vice President and Chief Financial Officer, Mark A. Herndon Format: Discussion of the second quarter of 2023 financial results followed by Q&A The replay
RADNOR, Pa., May 04, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced financial results for the three months ended March 31, 2023. FIRST QUARTER 2023 HIGHLIGHTS Financial Results Cash, cash equivalents and restricted cash totaled $18.8 million at March 31, 2023.The carrying value of the Company's ownership interests totaled $12.0 million at March 31, 2023. The total cost of the Company's ownership interests was $151.3 million.Net loss for the three months ended March 31, 2023 was $3.5 million, or $0.22 per share, as compared with a net loss of $6.7 million, or $0.40 per share, for the same period in 2022.
RADNOR, Pa., April 24, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) will release its financial results for the first quarter ended March 31, 2023 after the market close on Thursday, May 4, 2023. CONFERENCE CALL AND WEBCAST DETAILSPlease call 10-15 minutes prior to the call to register. Date: Thursday, May 4, 2023 Time: 5:00 pm ET Live Number: 877-407-0989 Webcast link: https://www.webcast-eqs.com/safeguardscientific050423 Speakers: Chief Executive Officer, Eric C. Salzman; and Senior Vice President and Chief Financial Officer, Mark A. Herndon Format: Discussion of the first quarter of 2023
RADNOR, Pa., March 09, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced financial results for the three months and year ended December 31, 2022. 2022 HIGHLIGHTS Exits & Deployments During the fourth quarter, Safeguard funded convertible loans of $0.5 million to meQuilibrium and $0.1 million from its subordinated line of credit to Trice Medical. Safeguard also funded an additional $0.25 million to Trice subsequent to the year-end pursuant to the same arrangement.Safeguard's annual deployments totaled $5.7 million, as compared to the full year 2022 estimated deployments of $5 million to $9 million. Safeguard Company Performanc